Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Wayne

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotoxFabian Müller, Tyler Cunningham, Stephanie Stookey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Feasibility of treating post-transplantation minimal residual disease in children with acute leukemiaNirali N Shah, Michael J Borowitz, Nancy C Robey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cellsHua Zhang, Yongzhi Cui, Nga Voong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation RelapseNirali N Shah, David M Loeb, Hahn Khuu, et al.
Blood|January 10, 2012
Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domainAndre Larochelle, Jennifer M Gillette, Ronan Desmond, et al.
Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantationNirali N Shah, Michael J Borowitz, Seth M Steinberg, et al.
Molecular Genetics and Metabolism|May 18, 2005
Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndromeWafika Zarzour, Robert Kleta, Haydar Frangoul, et al.
Pediatric Research|July 1, 2024
Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemiaRavi Bansal, Deepa Bhojwani, Bernice F Sun, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotoxFabian Müller, Tyler Cunningham, Stephanie Stookey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Feasibility of treating post-transplantation minimal residual disease in children with acute leukemiaNirali N Shah, Michael J Borowitz, Nancy C Robey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cellsHua Zhang, Yongzhi Cui, Nga Voong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation RelapseNirali N Shah, David M Loeb, Hahn Khuu, et al.
Blood|January 10, 2012
Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domainAndre Larochelle, Jennifer M Gillette, Ronan Desmond, et al.
Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantationNirali N Shah, Michael J Borowitz, Seth M Steinberg, et al.
Molecular Genetics and Metabolism|May 18, 2005
Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndromeWafika Zarzour, Robert Kleta, Haydar Frangoul, et al.
Pediatric Research|July 1, 2024
Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemiaRavi Bansal, Deepa Bhojwani, Bernice F Sun, et al.
Pageof 11